News
1 October 2026
Fonko Strengthens Indonesia’s Oncology Industry Capacity
JAKARTA — PT Fonko International Pharmaceuticals has recorded several key milestones in the development of oncology drug manufacturing in Indonesia. These achievements include securing European Union Good Manufacturing Practice (EU GMP) certification in 2025, developing a range of "first copy" products for cancer therapy, and obtaining halal certification for its…
25 September 2026
Consistently Maintaining Halal Standards, Dexa Group Wins IHYA 2026
TANGERANG — PT Ferron Par Pharmaceuticals, a member of Dexa Group, has won the 2026 Indonesia Halal Industry Award (IHYA) from the Ministry of Industry of the Republic of Indonesia in the Large Industrial Enterprise Category, Subcategory of Best Pharmaceuticals and Traditional Medicines. This award recognizes Dexa Group’s consistency in…
24 September 2026
From Medications to Facilities, Ferron Strengthens Support for Cancer Patients
JAKARTA — Indonesia recorded 474,083 new cases and 283,299 deaths due to cancer, according to 2024 Global Cancer Observatory (GLOBOCAN) data. This situation underscores the critical role of Ferron Par Pharmaceuticals in expanding its support for cancer patients—from delivering access to medications to strengthening chemotherapy support facilities through the provision…
12 August 2025
Dexa Group Forms Strategic Alliance with AC Health to Expand Access to Quality and Affordable Generic Medicines in the Philippines
MANILA — AC Health has formed a strategic alliance with Glorious Dexa Mandaya Philippines, a subsidiary of the Indonesian pharmaceutical company Dexa Group, to enhance the availability of quality and affordable medicines for Filipinos. The partnership will focus on distributing Dexa Group’s affordable medicines and healthcare products, leveraging AC Health’s…
22 July 2025
Promoting Quality Health: Dexa Medica Provides Free Chronic Disease Screening through “Cek Segitiga” in Karawang
Karawang, July 20, 2025 — Dexa Medica continues its commitment to public health by hosting another free “Cek Segitiga” health screening program, this time reaching residents at Karangpawitan Field, Karawang on Sunday (July 20, 2025). More than half of the screening participants were found to be at high risk for…
17 July 2025
15-Time Champion, Stimuno’s Top Brand Win Reflects Dexa Medica’s Commitment to Quality
JAKARTA – Stimuno has once again been awarded the Top Brand for Kids Award, a recognition of its long-standing commitment to consistent product quality—from halal assurance to production safety—reflecting Dexa Group’s core value of delivering only the best as the Reflection of Quality. The Top Brand for Kids Award is…
16 July 2025
Smart Moms Choose the Right Products
Folamil Genio soft capsules are a prenatal supplement from Dexa Medica that contain DHA, ARA, multivitamins, and minerals to support fetal development and maternal health throughout pregnancy.
25 June 2025
Dexa’s Cek Segitiga Detects Chronic Disease Risks in 6 Out of 10 Yogyakarta Residents
YOGYAKARTA – Dexa Medica’s free health screening program, Cek Segitiga, once again reached out to the people of Yogyakarta. Held at Alun-Alun Selatan on Sunday (June 22), the event revealed that over 60 percent of participants were classified as high-risk for chronic diseases—serving as a critical health alert for the…
21 May 2025
Free “Cek Segitiga” Health Screening by Dexa Medica: 73% of Participants Show Signs of Chronic Illness
As part of its preventive health efforts and to raise public awareness on the importance of early detection for chronic diseases, Dexa Medica—through its Corporate Social Initiative, *Dharma Dexa*—once again held the free health screening program Cek Segitiga. This time, the event was held in collaboration with Al Islam Hospital…
7 May 2025
Free “Cek Segitiga” Health Screening in Bogor: Growing Public Awareness on Early Detection of Chronic Diseases
Dexa Medica continues its commitment to promoting early detection of chronic illnesses by organizing the free health screening initiative, Cek Segitiga, in Bogor, West Java. The program offered free screenings to 490 residents for three major silent killers: hypertension, diabetes, and high cholesterol. This initiative is part of Dexa Group’s…